Cannabis Law Report

JUNE 4, 2021

(Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The post AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 appeared first on CannabisFN. AIkido Pharma Inc.:

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

OCTOBER 28, 2021

The email promoted a panel hosted by Clearmind Medicine, a company for which Haden sits on the advisory board. I intend to periodically send out information about events, publications and news stories that are relevant to those who are interested in our global process of turning psychedelics into medicines. Read full report.

Data 52

Data Clinical Trials Events Medicine 52

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021. More work is required to enhance health provider education regarding medicinal cannabis. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Medical Marijuana 411

MAY 10, 2022

The post Cornell University study shows a decline in prescription medicines in US states with legal adult-use cannabis appeared first on Medical Marijuana 411. The post Cornell University study shows a decline in prescription medicines in US states with legal adult-use cannabis appeared first on Medical Marijuana 411.

Medicine 59

Medicine Legalization Sleep Data 59

Cannabis Law Report

JANUARY 23, 2020

Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile. Timeline of Discovery and Owner Reaction. But rare are these times.

Data 59

Data Dispensary Patients Medicine 59

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

NORML

FEBRUARY 26, 2019

They look at this constantly, they look at the data, they look at the science and they make those recommendations to us on that basis.” When asked about the likelihood of the league changing its policies on the use of medical marijuana, Goodell answered, “We rely on our medical advisors to give us advice.

Access 203

Access Medicine Policy Media 203

Cannabis Law Report

APRIL 5, 2021

BASEL, Switzerland, April 5, 2021 /CNW/ — MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading clinical-stage psychedelic medicine biotech… Read More.

Data 87

Data Medicine Cannabis 87

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Veriheal

APRIL 23, 2024

California was the first state to legalize medicinal cannabis in 1996, right around the time that Gen Z began to enter society. Alternative medicines are a priority among Gen Z, who are moving away from traditional Western options and instead using natural wellness to support the mind and body.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

APRIL 1, 2022

Aguilar has suggested that “cannabis must have similar authorization and use conditions” to those that operate in Spain with products such as morphine and has opened the door for, at one time, community pharmacies -and not just hospital ones- dispense cannabinoid-based products that the Medicines Agency may authorize.

Medicine 52

Medicine Data Safety Conditions 52

Medical Marijuana Program Connection

MAY 21, 2023

Fully legalizing marijuana in Pennsylvania would require a robust regulatory framework, from licensing growers and distributors to tracking and collecting. Read More

Data 52

Data Marijuana Collective Legalization 52

Cannabis Law Report

FEBRUARY 8, 2022

New and revised guidance and forms for verified medicinal cannabis products have been published. Revisions have been made to provide up-to-date guidance to allow for changes to verified medicinal cannabis products, and to provide a specific form for starting material for export applications.

Medicine 52

Medicine Data Cannabis 52

Cannabis Law Report

DECEMBER 16, 2019

There’s a another medicinal cannabis company with its sights on the ASX boards. Emerald Clinics captures clinical data from patients to generate evidence for the safety and efficacy of cannabis medicines. Marta Pascual Juanola.

Medicine 59

Medicine Data Safety Therapy 59

Leaf Science

DECEMBER 28, 2018

The groundbreaking study conducted by New Frontier Data surveyed over 3,000 adult Americans to show people from all age groups and demographics in the U.S. 73% of medical cannabis users said that they used cannabis as a substitute for other medicines, while 41% used it as a replacement for over-the-counter painkillers.

Pharmaceutical 84

Pharmaceutical Data Recreational Topical 84

Cannabis Law Report

AUGUST 5, 2019

French patients who suffer from pain not treated by other medicines will be eligible, and the committee is looking for anyone in palliative care, epilepsy patients, and those suffering from the side effects of chemotherapy. Patients with muscle spasms related to multiple sclerosis are also invited to take part. billion ($3.2

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. “We hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

NORML

JUNE 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 349

Patients Chronic Pain Treatment Therapy 349

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients. The Canadian medicinal cannabis regime was established in the context of illegal cannabis use. It allows patients to have access to medicinal cannabis without danger of being criminalized.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

JUNE 23, 2021

States with mixed legality that includes medicinal programs, different laws governing CBD usage and, in some cases, decriminalized cannabis, ranked lowest in “cannabis curiosity”. The Google search data revealed a high volume of interest in legalization from those living in states where cannabis is already legal.

Data 66

Data Decriminalization Legalization Cannabis 66

Cannabis Law Report

DECEMBER 19, 2021

17 December 2021: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more. obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines). Prescription medicine. Prescription Medicine. Prescription Medicine.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. Prescription Medicine. Prescription Medicine. Prescription Medicine.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

JUNE 2, 2021

The latest article in Healthcare Business Today cites the company’s Multiomics Advanced Technology™ (MAT) as the driver for more accurate predictions about disease states and individual responses to diseases and treatments that will make medicine truly personalized.

Medicine 90

Medicine Business Treatment Data 90

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

FEBRUARY 5, 2022

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

MARCH 11, 2022

The Technical Note “Management of Cannabis Waste in the context of activities that produce cannabis for medicinal purposes” was published on 8 February 2022. the Portuguese National Authority for Medicines and Healthcare Products) and the APA – Agência Portuguesa do Ambiente, I.P.

Medicine 52

Medicine Treatment Packaging Digestion 52

Cannabis Law Report

DECEMBER 15, 2021

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Medicinal Genomics

MAY 31, 2018

Medicinal Genomics recently secured funding from the DASH network to create a better cannabis reference genome for controversially patented TypeII plants. Most of the cannabis reference genomes that are available now, including the two Medicinal Genomics sequenced in 2011, are not complete. The old publishing incentives are broken.

Medicine 75

Medicine Seed-To-Sale Cannabis Data 75

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

SEPTEMBER 28, 2021

The data will then be analysed to recognise trends in responses. • Participants: The survey is open to all ACT residents over 18 years. • Use of Data and Feedback: The data will be used in my ANIP thesis and possibly for future research. My ANIP host organisation (Johnathan Davis MLA’s office) may also use the data.

Therapy 52

Therapy Medicine Data Collective 52

Cannabis Law Report

DECEMBER 4, 2019

Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, This data shows that 97.4% (370 out of 380) samples fell at or below the 0.3% Dr. Snyder taught at Harvard University School of Medicine. 9-THC, severely limits the hemp strains a farmer can grow.

Data 59

Data THC Strains Concentrates 59